NCT04967053

Brief Summary

This study will be a retrospective study in which we will review patients who underwent laparoscopic sleeve gastrectomy at Sohag University Hospital in the period from january 2017 to May 2018.Assessment of outcomes as Effects on weight, Effects on co-morbidities and Post operative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 19, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

11 months

First QC Date

July 13, 2021

Last Update Submit

May 31, 2022

Conditions

Keywords

morbid obesitysleeve gastrectomybariatric surgeryweight loss

Outcome Measures

Primary Outcomes (1)

  • Effects on weight reported as percentage of excess weight loss

    It is calculated as (initial weight - follow-up weight)/(initial weight - ideal weight corresponding to BMI 25) × 100%.

    minimum 2-year follow-up

Interventions

Laparoscopic sleeve gastrectomy gives long-standing improvement or resolution of obesity-related conditions and also survival benefit. It is highly cost-effective. Surgical procedures for the treatment of obesity.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

both males and females, age from 18 to 65 yrs complain of obesity with body mass index ≥ 40 kg/m2 or body mass index ≥ 35 kg/m2 with comorbidities diseases.

You may qualify if:

  • age from 18 to 65 years old
  • body mass index ≥ 35 kg/m2 with comorbidities disease or body mass index ≥ 40 kg/m2, with failure of non operative attempts to lose weight
  • a minimum 2-year follow-up at our outpatient clinic.

You may not qualify if:

  • secondary causes of obesity (e.g. endocrine diseases)
  • patients unable to participate in medical follow-up;
  • associated comorbidities or diseases impacting on weight loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, 82524, Egypt

Location

MeSH Terms

Conditions

Obesity, MorbidWeight Loss

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

July 13, 2021

First Posted

July 19, 2021

Study Start

July 1, 2021

Primary Completion

May 20, 2022

Study Completion

May 20, 2022

Last Updated

June 1, 2022

Record last verified: 2022-05

Locations